跳到正文
原文
Medical Xpress·· 2026-10-14AI 评分51

系统综述:阿片类药物仅适用于短期急性疼痛管理,长期疗效存疑

Opioids only useful for short-term pain relief, study finds

AI 导读

阿尔伯塔大学团队在英国全科医学杂志发表的系统综述和Meta分析表明,阿片类药物在急性疼痛(4周内)中有效,但在慢性疼痛管理中超过12周可能无益甚至有害。该研究纳入了27项比较阿片类与非阿片类止痛药治疗骨关节炎或慢性腰痛的随机对照试验。

正文
opioids
Credit: Damian Sochacki from Pexels

Researchers from the University of Alberta have found that opioids are best used for acute pain relief for four weeks or less and may cause more harm than good when used for chronic pain for more than 12 weeks.

In a recently published paper in the British Journal of General Practice, the team reported on a systematic review of 27 randomized controlled trials comparing opioids with nonopioid pain management for the treatment of osteoarthritis or chronic low back pain.

The trials examined the ability of opioids such as oxycodone, buprenorphine, oxymorphone, hydromorphone and morphine to produce clinically meaningful pain relief—defined as 30% or more—over time.

Their analysis showed that, although opioids did work in the first four weeks of acute pain, they provided little or no benefit over longer periods and may worsen pain control beyond 12 weeks by potentially increasing the patient's sensitivity to pain.

"If someone breaks a limb, has surgery or a dental problem, where you anticipate the problem is going to resolve in a relatively short time, it's probably OK to give an opioid for that," says principal investigator Scott Garrison, a professor of family medicine, director of the Pragmatic Trials Collaborative and member of the PEER (Patients, Experience, Evidence, Research) team.

"Opioids still have a role in managing acute pain. But if the patient has a condition where this pain is going to be chronic, I think you should reconsider whether you should be offering an opioid, because you may only be giving very short-term pain relief with the possibility of worse pain in the long run, not to mention other potential problems from the opioids."

The research team recommends that further research on opioids be done to evaluate analgesia at multiple time points. They were also critical of a trial design known as "enriched enrollment randomized withdrawal," or EERW.

Rather than testing patients on new opioid prescriptions, it provides opioid medication to all participants for a number of weeks before the trial period, includes only patients who respond and then withdraws opioids from the control group.

"This trial design was excluded (from our analysis) because of a very high risk of bias—specifically, high risk of selection bias, unblinding of control participants as they withdraw from opioids and the potential for development of physical dependence or opioid-induced hyperalgesia during the run-in period," the U of A team reports.

Garrison says his study's results are particularly important for medical fields that see patients with chronic pain, such as family medicine, orthopedics and rheumatology.

Since completing the study a couple of years ago, he has shared the results with his own family practice patients with chronic pain.

"It's very hard to get people off opioids once they have started them, but when patients are given this information about potential harms, they don't want the drug," he says.

"Absolutely every patient who is told this up front ends up not taking the opioid. It's so hard to stop, but it's so easy not to start if people are fully informed."

Publication details

Liesbeth S Froentjes et al., Impact of treatment duration on the effectiveness of opioid analgesia: a systematic review and meta-analysis, British Journal of General Practice (2026). DOI: 10.3399/bjgp.2025.0705

Journal information: British Journal of General Practice

Who's behind this story?

Swati Mestri

Swati Mestri

Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Opioids only useful for short-term pain relief, study finds (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-opioids-short-term-pain-relief.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com